Evidence map›Paper›PMID 33527023›Full record

ArticleAmerican journal of translational research2021

Inhibition of mTORC1 in the rat condyle subchondral bone aggravates osteoarthritis induced by the overly forward extension of the mandible.

Yazhen Li, Jing Yang, Ying Liu, Xiao Yan, Qi Zhang, Junbo Chen, Qiang Zhang, Xiao Yuan

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Inhibition of mTORC1 by rapamycin results in feedback activation of AktbioRxiv : the preprint server for biology · 2025
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yazhen LiDepartment of Orthodontics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Jing YangQingdao Stomatological Hospital Qingdao, Shandong, China.
Ying LiuDepartment of Stomatology, Secondary Hospital of Shandong University Jinan, Shandong, China.
Xiao YanDepartment of Orthodontics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Qi ZhangDepartment of Orthodontics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Junbo ChenDepartment of Orthodontics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Qiang ZhangDepartment of Orthodontics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Xiao YuanDepartment of Orthodontics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Qingdao University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the role of mammalian target of rapamycin complex 1 (mTORC1) in the remodeling of the condyle subchondral bone in rats with temporomandibular joint osteoarthritis (TMJ OA) and explore the mechanisms involved. In this study, we used rats fitted with appliances to overly extend the mandible forward as an animal model of TMJ OA. Bone samples were collected 2, 4, and 8 weeks after appliance fixation. Histological changes in the condyle subchondral bone were assessed by staining with hematoxylin and eosin, safranin O, and tartrate-resistant acid phosphatase. Real-time polymerase chain reaction and immunohistochemical analyses were performed to evaluate the expression levels of osterix, runt-related transcription factor 2 (RUNX2), osteocalcin (OCN), and mTORC1 in the condyle subchondral bone. The dissected condyles were analyzed using a micro-CT scanner. We also investigated changes in the condyle subchondral bone after mTORC1 pathway inhibition. In the early stages of TMJ OA, preosteoblasts, osteoblasts, and osteoclasts of the condyle subchondral bone were activated, which stimulated subchondral bone loss. MTORC1 was activated in subchondral bone preosteoblasts in rats with TMJ OA. The mTORC1 pathway was inhibited by a local injection of rapamycin, and the number of osteoblasts and mRNA levels of osteogenic markers in the condyle subchondral bone decreased, but the number of osteoclasts was basically unchanged. As a result, in the early stages of TMJ OA, subchondral bone loss and aggravation of OA were observed. These findings suggest that the mTORC1 signaling pathway plays an important role in subchondral bone remodeling during early stages of TMJ OA.

Indexed as

mTORC1osteoarthritissubchondral boneTemporomandibular joint

Identifiers

PMID33527023
PMCPMC7847512
OpenAlexW3127517413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.